Back

IQVIA Holdings Inc

Ticker: IQV ISIN: US46266C1053
Add to portfolio Portfolio analysis in 2min
Stock Large-cap High beta Trading above 200-day average Near 52-week high
Market cap
$37.85B
P/E
30.57
Forward P/E
16.98
Profit margin
8.07%
Revenue growth QoQ
5.20%
Beta
1.37
$260.24 0.16%
Price as of 2026-08-24 · NYSE

Performance by timeframe

Rolling returns
1 Month +22.05%
6 Months +57.84%
1 Year +38.41%
5 Years +0.14% p.a.+0.68%
10 Years +12.90% p.a.+236.14%
Since inception +14.69% p.a.+518.00%
Calendar year returns
YTD +15.45%
2025 +14.71%
2024 -15.07%
2023 +12.93%
2022 -27.38%
2021 +57.47%

Key stats

Market cap
37.85B
P/E
30.57
Beta
1.37
52-week range
134.65 - 234.30
50-day MA
216.12
200-day MA
181.12
Section 1

Business overview

Company profile data from fundamentals.

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. It has a strategic collaboration with Sarah Cannon Research Institute to enhance clinical trial processes. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is based in Durham, North Carolina.

Sector Healthcare
Industry Diagnostics & Research
Country United States
Exchange NYSE
Section 2

Financial quality

Above-average volatility

Profitability and balance-sheet quality indicators from reported fundamentals.

Profitability

ROE 19.37%
ROA 5.07%
Profit margin 8.07%
Operating margin 13.98%
PEG ratio 0.94
Revenue/share TTM 91.31
Revenue TTM 15.90B
EBITDA 2.93B
Gross profit TTM 5.37B
Beta 1.37

Valuation

Trailing P/E 30.57
Forward P/E 16.98
P/B 6.14
P/S 2.38
EV/EBITDA 14.87
EV/Revenue 3.21

ESG Scores

Total ESG 26.8
Environment 1.2
Social 14.8
Governance 6.9
Section 3

Earnings

Earnings metrics from company highlights and earnings datasets.

EPS estimate (current year) 11.89
Quarterly earnings growth 24.50%
Revenue TTM 15.90B
Reported quarters 52
Section 4

Dividends & corporate actions

Dividend and split fields from fundamentals.

Forward annual div. yield 0.00%
Last split date 0000-00-00
Section 5

Ownership / analyst view

Institutional ownership and analyst estimate fields when available.

Analyst

Analyst target price $250.00
Analyst rating 4.3044

Ownership & short interest

Shares outstanding 170.30M
Shares float 161.74M
Institutional ownership 100.61%
Insider ownership 1.05%
Short ratio 3.65
Short % of float 3.78%

Details

Instrument metadata and source update timestamps.

Symbol IQV
Name IQVIA Holdings Inc
Asset type STOCK
Exchange NYSE
Currency USD
ISIN US46266C1053
Country USA
Code + exchange IQV.NYSE
Fundamentals updated 2025-12-15

The information provided on this platform is for informational purposes only and should not be considered as financial or investment advice. Insightfolio does not provide investment advice, personalized recommendations, or guidance regarding the purchase, holding, or sale of financial assets. The tools and content are intended for educational purposes only and are not tailored to individual circumstances, financial needs, or objectives.

Insightfolio assumes no liability for the accuracy, completeness, or reliability of the information presented. Users are solely responsible for verifying the information and making independent decisions based on their own research and careful consideration. Use of the platform should not replace consultation with qualified financial professionals.

Investments involve risks. Users should be aware that the value of investments may fluctuate and that past performance is not an indicator of future results. Investment decisions should be based on personal financial goals, risk tolerance, and independent evaluation of relevant information.

Insightfolio does not endorse or guarantee the suitability of any particular financial product, security, or strategy. Any projections, forecasts, or hypothetical scenarios presented on the platform are for illustrative purposes only and are not guarantees of future outcomes.

By accessing the services, information, or content offered by Insightfolio, users acknowledge and agree to these terms of the disclaimer. If you do not agree to these terms, please do not use our platform.

Instrument logos provided by Elbstream.